[Federal Register: January 27, 2004 (Volume 69, Number 17)]
[Notices]               
[Page 3946]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27ja04-117]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.33(a) of title 21 of the Code of Federal 
Regulations (CFR), this is notice that on October 21, 2003, Noramco, 
Inc., 1440 Olympic Drive, Athens, Georgia 30601, made application by 
renewal to the Drug Enforcement Administration (DEA) for registration 
as a bulk manufacturer of the basic classes of controlled substances 
listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Oxycodone (9143)...........................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
Sufentanil (9740)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to support its other manufacturing facility with 
manufacturing and analytical testing.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: Federal Register Representative Office 
of Chief Counsel (CCD) and must be filed no later than March 29, 2004.

    Dated: December 24, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-1653 Filed 1-26-04; 8:45 am]

BILLING CODE 4410-09-M